Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
ATAGI flagged worrying vaccine coverage declines and renewed disease threats, with pharmacists tipped to boost community protection.
PSA announced it has signed an agreement to acquire the Australasian College of Pharmacy, marking a significant step for expanding education.
Serious adverse events in infants prompted the Therapeutic Goods Administration to issue a safety alert about this anaesthetic cream.
Half of Australia has funded the roll out of the intranasal influenza vaccine, Flumist in 2026. Here's what pharmacists need to know.
Pharmacy interventions in asthma management can be difficult because patients often don’t understand the underlying nature of the condition.
On 1 October 2025, the TGA scheduled methenamine hippurate as a Pharmacist Only medicine to ensure pharmacist oversight of its use.
Yesterday (Tuesday 7 October), PSA, in a joint event with Consumer Healthcare Products Australia (CHP Australia), showcased the breadth of pharmacists’ skills and roles at Australian Parliament House.
So who were the pharmacists walking in the corridors of power? And...
Last year, the TGA made an interim decision to reschedule Rikodeine to a prescription medicine. Why hasn’t it happened yet?
Last year, it was reported that Australian poisons hotlines received almost 1,500 calls about child ingestion of melatonin.
Adolescents prefer seeking contraceptive care from pharmacists, says new research. But there are barriers to access that must be addressed.
